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Replacement Lighting for the International Space Station 
The International Space Station (ISS) currently uses General Luminaire Assemblies (GLAs) as its 
primary light source.  These GLAs are composed of fluorescent lighting and are integrated into 
the electrical system on Station. Seventy seven of these units are distributed throughout the 
vehicle, and many of the lights, having reached their lifespan, are no longer functional; while 
backup panels are available on orbit, it is anticipated that the supplies of fluorescents on the 
station will be exhausted by 2015.   
 
The ISS vehicle office is therefore preparing to replace all of the GLAs, with Solid State Light 
Assemblies (SSLAs) composed of white Light Emitting Diodes (LEDs).  In the Spring of 2010, an 
announcement for the replacement lights was released. The announcement specified that 
proposed lighting systems should use LED technology, given certain power draw restrictions 
and no changes to how the lights are currently controlled (a central on/off switch per node, and 
a dial to turn on/off and increase brightness on each lighting unit). The replacement lights are 
to follow current specifications for brightness levels (lux) and color temperature (degrees 
Kelvin, or K).  
 
Reportedly, the lighting on orbit is dim and suboptimal. The average brightness of the lights 
(given all lights within a node are operational) is 291 lux; by comparison, recommended office 
lighting ranges from 200 to 500 lux, and daylight ranges on a typical overcast day, consists of 
10,000 to 25,000 lux. Representatives from NASA Behavioral Health and Performance Element 
(BHP) and Human Factors and Habitability identified that maintaining current brightness levels 
limits visual acuity, work space, and the use of light as a countermeasure for improving 
circadian entrainment, hastening phase shifting, evoking acute alertness and enhancing 
performance. Revised lighting specifications are therefore needed to optimize the replacement 
lights for the ISS. 
 
Enhanced Brightness for Visual Acuity and Workspace 
Brightness levels vary throughout the eight nodes on the ISS. Tasks requiring high visibility 
therefore, are limited to the more brightly light areas on the station. Allowing for an increased 
maximum brightness of all the units will permit high illumination tasks such as precision 
inspection and maintenance, and medical tasks such as examination of the eye, suturing, and 
test tube intubation, to be performed throughout the vehicle. Based on expert analysis, a 
recommendation was made to enhance the replacement lights so that they are capable of 
producing an average brightness level of 3200 lux (from current average of 291 lux). 
Additionally, each light should be dimmable so that brightness can be adjusted as needed. 
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Enhanced Brightness for Circadian Entrainment and Phase Shifting 
There are additional benefits to crew safety, health and performance to be gained from 
enhanced lighting system. Human health risks – particularly the risk of performance errors due 
to fatigue resulting from sleep loss, circadian desynchronization, extended wakefulness and 
work overload- can also be mitigated. 
Due to operational constraints, ISS crew members regularly endure phase shifts to their 
work/rest schedules. As a result, critical operation tasks must sometimes be performed during 
the subjective night, and sleep must be attained during the subjective day. Reduced sleep 
duration is a common outcome of this scenario. Objective evidence from Shuttle missions (ISS 
data collection is currently ongoing) reveals that the average total nightly sleep duration in 
flight is around 6 hours (Barger and Czeisler, 2008). Ground studies clearly demonstrate that 
sleep in quantities as experienced by astronauts leads to lapses of attention equivalent to those 
seen after one night’s total sleep deprivation (Van Dongen, Dinges et al., 2003; Belenky et al., 
2003). Not surprisingly, sleep medications are used as a primary mitigation strategy in space 
(Putcha et al.,1999; Barger and Czeisler, 2009). 
As demonstrated in numerous laboratory investigations, enhanced brightness allows for a non-
pharmaceutical countermeasure for improving circadian entrainment, hastening phase shifting, 
evoking acute alertness, and enhancing performance (Riemersma-van der Lek, et al., 2008; 
Phipps-Nelson et al., 2003; Zeitzer et al., 2000; Cajochen et al., 2000; Steward et al., 1995).  
Flexible Spectral Power Distribution  
Lights are typically made up of one spectral power distribution (SPD) which characterizes the 
radiant power emitted by the source at each wavelength or band of wavelengths over the 
visible region (380 to 760 nanometer wavelengths, or nm). The planned replacement lights for 
the ISS are to include one SPD.  
Lights equipped with multiple spectral power distributions allow for an even more potent 
countermeasure. Research has demonstrated that specific wavelengths, at certain times of day, 
can elicit neurobehavioral outcomes. For example, monochromatic blue light (~470 mm) is 
more effective than white light for phase shifting, melatonin suppression, and increasing 
alertness and performance (Brainard et al., 2001; Lockley et al., 2003, 2006), while recent 
evidence indicates monochromatic green light may be more effective than blue under dim light 
conditions (Gooley et al., 2010). Additionally, polychromatic light – light that appears white -- 
that is enriched in the blue portion of the spectrum is more potent biologically than typical 
white fluorescent light (Brainard et al., 2010).  
An ideal lighting system would allow crew members to enrich lights with specific wavelengths 
based on the desired outcome. A spectrum that de-emphasizes wavelengths of light (~470nm) 
can be used in the off-duty, pre-bedtime period to promote sleep onset while a spectrum that 
emphasizes wavelengths of light (~470 nm) could be used to promote alertness (Figures 1 and 
2). A range of spectrums in one lighting unit, therefore, allows for multiple applications of light 
in the same place. Recommended SPDs are being prepared for the planned ISS replacement 
lights.  
   
Figure 1: Pre-Sleep (de-emphasize blue)  Figure 2: Awakening (emphasize blue) 
Operational Use of Enhanced LEDs on ISS 
The lighting specifications – increased brightness capability (lux) and multiple spectral power 
distributions (nm) – provided are based on scientific and evidence, and will optimize light as an 
inflight countermeasure. One must, however, consider the use of these lights in the operational 
environment. As previously mentioned, no changes to the control of the lights from the way 
they are currently controlled, can be made: if crew members therefore want to dim brightness 
or enrich wavelengths, in the current scenario they must manually change each light within a 
node. As a result, an integrated wireless solution is being developed through which a remote 
device could control each of the various LEDs outputs between 0 and 100%, and would allow 
for fine spectrum (color mixing) and lux level adjustment, in addition to logging of lighting 
spectrums over time. Other aspects for making the lights usable in the operational environment 
would include a hard three-way toggle switching the light’s spectrum between two preset 
countermeasure spectrums (“Entrainment CM” and “Pre-sleep CM”) and a preset for 
supporting crewmember vision. 
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